As Lykos Therapeutics awaits an FDA decision this week on its proposed MDMA-assisted therapy for PTSD, the company has announced new initiatives and measures for additional oversight if the therapy is approved.
In part two of our special report on the pending FDA decision on MDMA-Assisted Therapy we look at comments from stakeholders with PTSD and also veterans groups about the benefits of the treatment and possible bias by researchers and managers at Lykos Therapeutics.
As Lykos Therapeutics considers a Risk Evaluation and Mitigation Strategy for MDMA-assisted therapy, both supporters and detractors of MDMA-AT make their case for whether the treatment is safe for patients.
Lykos Therapeutics details how it is addressing questions raised by FDA advisors during a June 4 advisory meeting and how it will apply these insights to its Risk Evaluation and Mitigation Strategy.
The growing market for vaporizers that offers portable, disposable and convenient delivery systems for DMT, psilocybin, 2C-B and other psychedelic substances.
The executive director of the American Psychedelic Practitioners Association shares his vision for the professionalization of psychedelic-assisted therapy, as FDA approval seems likely this year.
The MAPS nonprofit remains the largest shareholder, but gives up controlling interest in MAPS PBC, as the for-profit company that seeks to commercialize MDMA therapy successfully attracts investors.
Dan Love, co-founder of Beckley Waves, talks about the at-home ketamine business, the value of technical infrastructure, and the psychedelic field’s current consolidation.
**Contribute to the Future of Psychedelics** Make an investment in a healthy psychedelic future by supporting this community-funded initiative. For the last 3 years, Lucid News has been providing indispensable journalism covering the psychedelic field. We are now turning to our readers to continue building. We understand that not everyone is in a position to pay for this vital information, but if you are, we need you. *Make an investment in quality journalism, so others can benefit. You can give just once or monthly. Thank you.*
**Contribute to the Future of Psychedelics** Make an investment in a healthy psychedelic future by supporting this community-funded initiative. For the last 3 years, Lucid News has been providing indispensable journalism covering the psychedelic field. We are now turning to our readers to continue building. We understand that not everyone is in a position to pay for this vital information, but if you are, we need you. *Make an investment in quality journalism, so others can benefit. You can give just once or monthly. Thank you.*